Informationes plurimae ― Latine

Scleroderma, morbus rarus, est circa telae nota afficiens, ostendens cutem induratam et alias partes corporis interdum impactas. Duo genera principalia sunt: systemic sclerosis, quae cutem duritiam et viscera interiora involvit, atque localized scleroderma, quae etiam morphea nota est, quae proprie cuti et fibris subest circumscripta, cum cursu benigno et auto‑limitatum. Etiam si localized scleroderma raro occurrit et eius causa obscura est, recentissima investigatio suadet quod etiam organa interna afficere possit et varias quaestiones sanitatis provocare. Prae‑matura curatio pendet ne inpedimenta, gravitas potentiae localized scleroderma, augere possint.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.

Morphea, etiam scleroderma locale notum, rara morbus autoimmune est, qui textum connectens afficit. Variis modis se manifestare potest, et non est admodum commune, cum incidens 0,4‑2,7 per 100 000 hominum quolibet anno. Morphea saepe inter aetates 2‑14 annorum cernitur, et puellas saepius quam pueros afficit.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.